Sandoz Group AG

🇩🇪Germany

Country: 🇩🇪Germany

Ownership: Public

Established: 1986-01-01

Employees: 20K

Market Cap: $19B

Website: http://www.sandoz.com

Clinical Trials

To Demonstrate the Relative Bioequivalency Comparing Geneva's 10 mg Glipizide Tablets To Roerig's 10 mg Glucotrol Tablets

Phase 1

Completed

Conditions: Type 2 Diabetes

Interventions: Drug: Glipizide 10 mg Tablets (Geneva Pharmaceutical, Inc.)
Drug: Glucotrol 10 mg Tablets (Roerig Pharmaceutical, Inc.)

First Posted Date: 2009-07-27

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 28

Registration Number: NCT00946504

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

Phase 1

Completed

Conditions: Seizure

Interventions: Drug: Levetiracetam Tablets, 750 mg (Sandoz Inc.)
Drug: Keppra (Levetiracetam) Tablets, 750 mg (UCB Pharma, Inc)

First Posted Date: 2009-07-27

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 20

Registration Number: NCT00946751

To Demonstrate the Relative Bioavailability of Hydroxychloroquine Sulfate, 200 mg Tablets

Phase 1

Completed

Conditions: Immunosuppression
Rheumatism

Interventions: Drug: Hydroxychloroquine Sulfate Tablets, 200 mg, Plaquenil (Sanofi Winthrop)
Drug: Hydroxychloroquine Sulfate Tablets, 200 mg (Geneva Pharmaceutical, Inc.)

First Posted Date: 2009-07-27

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 72

Registration Number: NCT00946790

To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Fasting Conditions

Phase 1

Completed

Conditions: Nausea
Vomiting

Interventions: Drug: Ondansetron HCl 24 mg Tablets (Sandoz, Inc.)
Drug: Zofran (Ondansetron HCl) 24 mg Tablets (GlaxoSmithKline)

First Posted Date: 2009-07-27

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 26

Registration Number: NCT00946387

To Demonstrate the Relative Bioavailability Study of Loratadine 10 mg Tablets

Phase 1

Completed

Conditions: Allergy

Interventions: Drug: Loratadine 10 mg Tablets Under Fasting Conditions (Sandoz, Inc.)
Drug: Loratadine 10 mg Tablets Under Fed Conditions (Sandoz, Inc.)
Drug: Claritin (Loratadine) 10 mg Tablets Under Fed Conditions (Schering)

First Posted Date: 2009-07-27

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 30

Registration Number: NCT00946608

To Demonstrate the Relative Bioavailability Study of Promethazine HCl 50 mg Tablets Under Fasting Conditions

Phase 1

Completed

Conditions: Allergy

Interventions: Drug: Phenergan (Promethazine HCl) 50 mg Tablets (Wyeth Laboratories)
Drug: Promethazine HCl 50 mg Tablets (Sandoz, Inc)

First Posted Date: 2009-07-27

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 36

Registration Number: NCT00947063

To Demonstrate the Relative Bioavailability of Fluoxetine Hydrochloride Capsules, 40 mg

Phase 1

Completed

Conditions: Depression

Interventions: Drug: Fluoxetine Hydrochloride Capsules, 40 mg (Prozac) (Eli Lilly)
Drug: Fluoxetine Hydrochloride Capsules, 40 mg (Geneva Pharmaceutical, Inc)

First Posted Date: 2009-07-27

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 30

Registration Number: NCT00947076

To Demonstrate the Relative Bioavailability Study of Ramipril 10 mg Capsules Under Non-Fasting Conditions

Phase 1

Completed

Conditions: Hypertension

Interventions: Drug: Altace (Ramipril) 10 mg Capsule (Aventis Pharmaceutical)
Drug: Ramipril 10 mg Capsule (Sandoz)

First Posted Date: 2009-07-27

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 48

Registration Number: NCT00946621

To Demonstrate the Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fasting Conditions

Phase 1

Completed

Conditions: Hypertension

Interventions: Drug: Ramipril 10 Capsule (Sandoz)
Drug: Altace (Ramipril) 10 Capsule (Aventis Pharmaceutical)

First Posted Date: 2009-07-27

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 48

Registration Number: NCT00946465

To Demonstrate the Relative Bioavailability of Atenolol Tablets, 100 mg

Phase 1

Completed

Conditions: Hypertension
Angina

Interventions: Drug: Atenolol (Tenormin) 100 mg Tablets Zeneca (Astra Zeneca Pharmaceutical)
Drug: Atenolol 100 mg Tablets (Geneva Pharmaceutical, Inc.)

First Posted Date: 2009-07-27

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 28

Registration Number: NCT00946725

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy